Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $89.12 +0.27%
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
General and administrative expenses: 2.28M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.29), $0.09 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $45.89 million versus the consensus estimate of $37.52 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdStrike shares jump on earnings beat, raised outlook
- CrowdStrike Holdings Inc. (CRWD) Tops Q2 EPS by 2c, Beats on Revenue; Offers FY Guidance
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
